MML Investors Services’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $37.7M | Buy |
482,378
+129,826
| +37% | +$10.5M | 0.08% | 267 |
|
|
2026
Q1 | $30.5M | Sell |
352,552
-28,632
| -8% | -$2.74M | 0.08% | 239 |
|
|
2025
Q4 | $36.6M | Buy |
381,184
+42,584
| +13% | +$4.14M | 0.09% | 219 |
|
|
2025
Q3 | $32.2M | Buy |
338,600
+12,117
| +4% | +$1.11M | 0.09% | 224 |
|
|
2025
Q2 | $28.5M | Buy |
326,483
+8,693
| +3% | +$737K | 0.08% | 236 |
|
|
2025
Q1 | $28.6M | Buy |
317,790
+32,472
| +11% | +$2.91M | 0.1% | 216 |
|
|
2024
Q4 | $22.8M | Buy |
285,318
+34,218
| +14% | +$2.96M | 0.08% | 251 |
|
|
2024
Q3 | $22.6M | Buy |
251,100
+4,709
| +2% | +$396K | 0.08% | 244 |
|
|
2024
Q2 | $19.4M | Sell |
246,391
-32,487
| -12% | -$2.66M | 0.08% | 252 |
|
|
2024
Q1 | $24.3M | Sell |
278,878
-2,135
| -0.8% | -$182K | 0.1% | 213 |
|
|
2023
Q4 | $23.1M | Sell |
281,013
-42,226
| -13% | -$3.22M | 0.11% | 207 |
|
|
2023
Q3 | $25.3M | Buy |
323,239
+18,024
| +6% | +$1.51M | 0.14% | 156 |
|
|
2023
Q2 | $26.9M | Buy |
305,215
+49,526
| +19% | +$4.26M | 0.15% | 155 |
|
|
2023
Q1 | $20.6M | Buy |
255,689
+375
| +0.1% | +$30.6K | 0.15% | 157 |
|
|
2022
Q4 | $19.8M | Buy |
255,314
+31,540
| +14% | +$2.56M | 0.13% | 175 |
|
|
2022
Q3 | $18.1M | Buy |
223,774
+8,317
| +4% | +$747K | 0.14% | 167 |
|
|
2022
Q2 | $19.3M | Buy |
215,457
+2,463
| +1% | +$250K | 0.15% | 158 |
|
|
2022
Q1 | $23.6M | Buy |
212,994
+19,775
| +10% | +$2.09M | 0.17% | 127 |
|
|
2021
Q4 | $20M | Buy |
193,219
+12,453
| +7% | +$1.44M | 0.14% | 155 |
|
|
2021
Q3 | $22.7M | Buy |
180,766
+12,625
| +8% | +$1.63M | 0.18% | 123 |
|
|
2021
Q2 | $20.9M | Sell |
168,141
-1,585
| -0.9% | -$199K | 0.18% | 131 |
|
|
2021
Q1 | $20.1M | Buy |
169,726
+17,642
| +12% | +$2.07M | 0.19% | 125 |
|
|
2020
Q4 | $17.8M | Buy |
152,084
+9,982
| +7% | +$1.1M | 0.19% | 124 |
|
|
2020
Q3 | $14.8M | Buy |
142,102
+6,580
| +5% | +$661K | 0.19% | 129 |
|
|
2020
Q2 | $12.4M | Buy |
135,522
+16,275
| +14% | +$1.56M | 0.17% | 145 |
|
|
2020
Q1 | $10.8M | Buy |
119,247
+12,526
| +12% | +$1.33M | 0.19% | 135 |
|
|
2019
Q4 | $12.1M | Buy |
106,721
+12,393
| +13% | +$1.36M | 0.17% | 151 |
|
|
2019
Q3 | $10.2M | Sell |
94,328
-9,857
| -9% | -$1.03M | 0.17% | 148 |
|
|
2019
Q2 | $10.1M | Buy |
104,185
+10,511
| +11% | +$960K | 0.15% | 167 |
|
|
2019
Q1 | $8.53M | Buy |
93,674
+13,823
| +17% | +$1.24M | 0.13% | 181 |
|
|
2018
Q4 | $7.26M | Buy |
79,851
+2,710
| +4% | +$253K | 0.13% | 187 |
|
|
2018
Q3 | $7.59M | Buy |
77,141
+19,488
| +34% | +$1.8M | 0.13% | 184 |
|
|
2018
Q2 | $4.94M | Buy |
57,653
+8,099
| +16% | +$676K | 0.11% | 195 |
|
|
2018
Q1 | $3.98M | Buy |
49,554
+4,211
| +9% | +$347K | 0.08% | 220 |
|
|
2017
Q4 | $3.66M | Buy |
45,343
+8,103
| +22% | +$649K | 0.07% | 230 |
|
|
2017
Q3 | $2.9M | Buy |
37,240
+2,370
| +7% | +$197K | 0.06% | 258 |
|
|
2017
Q2 | $3.1M | Buy |
34,870
+5,606
| +19% | +$473K | 0.06% | 242 |
|
|
2017
Q1 | $2.36M | Buy |
+29,264
| New | +$2.29M | 0.05% | 145 |
|
Other funds holding MDT
MGP
MML Investors Services's MDT Position: Q2 2026 in Review
MML Investors Services increased its Medtronic (MDT) stake by 37% in Q2 2026, buying an estimated $10.5M and bringing the position to 482,378 shares worth $37.7M. The position accounts for 0.08% of the portfolio, ranked #267.
MML Investors Services first reported a position in MDT in Q1 2017 and has held it in 38 quarters since. 1,329 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- MML Investors Services held 482,378 shares of Medtronic worth $37.7M as of Q2 2026.
- MML Investors Services bought 129,826 Medtronic shares in Q2 2026, an estimated $10.5M.
- Medtronic made up 0.08% of MML Investors Services's portfolio in Q2 2026, its #267 holding.
- MML Investors Services first reported a position in Medtronic in Q1 2017 and has held it in 38 quarters since.
- 1,329 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.